Maze Therapeutics raises $191 million to figure out why some mutations causes genetic disease, and others don’t
Thursday, February 28, 2019 - 07:20
in Biology & Nature
The firm is building a platform to discover and drug genetic modifiers, genes that can negate the harmful effects of other genes